CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
133 hedge funds and large institutions have $555M invested in CTI BioPharma Corp. (DE) Common Stock in 2022 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 48 increasing their positions, 44 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% less call options, than puts
Call options by funds: $5.83M | Put options by funds: $7.21M
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
133
Holding in Top 10
4
Calls
$5.83M
Puts
$7.21M
Top Buyers
| 1 | +$22.7M | |
| 2 | +$11.6M | |
| 3 | +$9.51M | |
| 4 |
Millennium Management
New York
|
+$9.23M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$7.49M |
Top Sellers
| 1 | -$25.4M | |
| 2 | -$13.4M | |
| 3 | -$7M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$4.91M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.33M |